Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D V Jackson

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
American Journal of Clinical Oncology|October 1, 1986
Moderate-dose vincristine infusion in refractory breast cancerD V Jackson, D R White, C L Spurr, et al.
Cancer Treatment Reports|February 1, 1987
Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association StudyJ B Craig, B L Powell, D V Jackson, et al.
American Journal of Clinical Oncology|February 1, 1987
Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexateJ B Craig, D V Jackson, F R Richards, et al.
Gynecologic Oncology|October 1, 1986
Vincristine infusion in refractory gynecologic malignanciesD V Jackson, V W Jobson, H D Homesley, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Actinomycin D in the treatment of advanced breast cancerR A Grimm, H B Muss, D R White, et al.
American Journal of Clinical Oncology|October 1, 1984
A phase II study of dibromodulcitol (DBD) in stage IV melanomaJ Hopkins, F Richards, D Case, et al.
Cancer Treatment Reports|November 1, 1981
Pharmacokinetics of vincristine infusionD V Jackson, V S Sethi, C L Spurr, et al.
Cancer Treatment Reports|June 1, 1985
Interferon and doxorubicin in renal cell carcinomaH B Muss, C Welander, M Caponera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
A phase II study of recombinant alpha interferon in patients with recurrent or metastatic breast cancerH B Muss, R A Kempf, S Martino, et al.
Investigational New Drugs|February 1, 1990
A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphomaH B Muss, N Spell, D Scudiery, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
American Journal of Clinical Oncology|October 1, 1986
Moderate-dose vincristine infusion in refractory breast cancerD V Jackson, D R White, C L Spurr, et al.
Cancer Treatment Reports|February 1, 1987
Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association StudyJ B Craig, B L Powell, D V Jackson, et al.
American Journal of Clinical Oncology|February 1, 1987
Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexateJ B Craig, D V Jackson, F R Richards, et al.
Gynecologic Oncology|October 1, 1986
Vincristine infusion in refractory gynecologic malignanciesD V Jackson, V W Jobson, H D Homesley, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Actinomycin D in the treatment of advanced breast cancerR A Grimm, H B Muss, D R White, et al.
American Journal of Clinical Oncology|October 1, 1984
A phase II study of dibromodulcitol (DBD) in stage IV melanomaJ Hopkins, F Richards, D Case, et al.
Cancer Treatment Reports|November 1, 1981
Pharmacokinetics of vincristine infusionD V Jackson, V S Sethi, C L Spurr, et al.
Cancer Treatment Reports|June 1, 1985
Interferon and doxorubicin in renal cell carcinomaH B Muss, C Welander, M Caponera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
A phase II study of recombinant alpha interferon in patients with recurrent or metastatic breast cancerH B Muss, R A Kempf, S Martino, et al.
Investigational New Drugs|February 1, 1990
A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphomaH B Muss, N Spell, D Scudiery, et al.
Pageof 10